Daily Bulletin

Men's Weekly

.

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

Composition of Matter Patent Covers More than 80 Novel Compounds

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the...

Read more: Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including...

Business News

3PL Logistics in Australia: Strengthening Supply Chains for Growing Businesses

Australia’s vast geography and diverse consumer markets make logistics a critical part of business success. As companies scale and customer expectations rise, many turn to 3pl logistics australia to...

Daily Bulletin - avatar Daily Bulletin

Why Choosing The Right Shopify Web Developer Shapes Long-Term Ecommerce Success

Building a Shopify store that performs reliably over time requires more than surface-level setup. Working with an experienced Shopify web developer ensures that the platform is configured with inten...

Daily Bulletin - avatar Daily Bulletin

Robot Trading and Automation: Does Automated Trading Really Work?

In today’s fast-moving financial markets, many new and experienced traders wonder whether automated trading systems — often called trading robots, expert advisors (EAs), or algorithmic bots — can real...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business